Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

In multiple myeloma patients, autologous stem cell transplants abrogate the difference of treating them with two or three drug combinations: Real world data from a single institution in a middle-income country.

Sofía Chávez Martínez, Lidia Alberto López, Olivia Lira Lara, Miguel Viveros Lugo, Michelle Lavoignet Cisneros, Mónica Salgado Cabrera, Miguel Gómez Cabrera, Guillermo Álvarez Silva, Max Robles Nasta, Juan Olivares-Gazca, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7604.

https://doi.org/10.1182/blood-2025-7604

Published: 2025

Journal Articles

The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants.

Michelle Lavoignet Cisneros, Miguel Viveros Lugo, Max Robles Nasta, Sofía Chávez Martínez, Lidia Alberto López, Mónica Salgado Cabrera, Juan Olivares-Gazca, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7703.

https://doi.org/10.1182/blood-2025-7703

Published: 2025

Journal Articles

Enumeration of plasma cells in the bone marrow of persons with multiple myeloma: Correlation between conventional panoptical microscopy of the aspirate, flow cytometry and bone marrow biopsy.

Miguel Gómez Cabrera, Lidia Alberto López, Sofía Chávez Martínez, Miguel Viveros Lugo, Mónica Salgado Cabrera, Michelle Lavoignet Cisneros, Max Robles Nasta, Juan Olivares-Gazca, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7537.

https://doi.org/10.1182/blood-2025-7537

Published: 2025

Journal Articles

Castleman disease as a spectrum: Characterization of novel subtypes using data from the spanish GELTAMO registry

Blood (2025) 146 (Supplement 1): 1233.

https://doi.org/10.1182/blood-2025-1233

Published: 2025

Journal Articles

Evaluating a doctor-in-the-loop AI-agent for multiple myeloma chart reviews

Karla Mariana Castro Bórquez, Juan Pablo Capdevila, Jennifer Ahlstrom, Jay Hydren, Alejandro Lopez, Jorge Alberto López Carlos, Andrea Victoria Pacheco, Ana Echenique Alcázar, Edgar Ricardo Olivas Domínguez, Eduardo Franco Hernandez, Miranda De la Luz Franco, Martha Paola Anchondo Commesse, Magaly Valeria Escobedo Cruz, ANA Sahagun, Jorge Arturo Hurtado Martinez

Blood (2025) 146 (Supplement 1): 4424.

https://doi.org/10.1182/blood-2025-4424

Published: 2025

Journal Articles

The number of CD34 cells employed in autologous hematopoietic stem cell transplantation in persons with multiple sclerosis is unrelated to the neurological outcome of the procedure. experience in 1417 patients.

Michelle Lavoignet Cisneros, Olivia Lira Lara, Miguel Viveros Lugo, Sofía Chávez Martínez, Mónica Salgado Cabrera, Lidia Alberto López, Gabriela Flores Vargas, Juan Olivares-Gazca, Max Robles Nasta, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7617.

https://doi.org/10.1182/blood-2025-7617

Published: 2025

Journal Articles

Patients with multiple sclerosis above age 60 have neurological responses to autologous hematopoietic stem cell transplants similar to younger individuals: A single center experience

Miguel Viveros Lugo, Lidia Alberto López, Michelle Lavoignet Cisneros, Max Robles Nasta, Sofía Chávez Martínez, Mónica Salgado Cabrera, Miguel Gómez Cabrera, Shamira González Vázquez, Juan Olivares-Gazca, Guillermo Álvarez Silva, Guillermo Ruiz-Delgado, Guillermo Ruiz-Arguelles

Blood (2025) 146 (Supplement 1): 7615.

https://doi.org/10.1182/blood-2025-7615

Published: 2025

Journal Articles

Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance ?

Blood (2024) 144 (Supplement 1): 4422.

https://doi.org/10.1182/blood-2024-211078

Published: 2024

Journal Articles

Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study

Blood (2024) 144 (Supplement 1): 4403.

https://doi.org/10.1182/blood-2024-209936

Published: 2024

Journal Articles

Treatment-Related Neuropathy Following Brentuximab-Vedotin in African Americans Treated for Lymphoma: A Retrospective Chart Review

Carlos Alberto Lopez, Tyler Franklin Simonek, Mosope Folashade Balogun, Kimberly Janelle Noriega, Samuel Ogunbode, Khadijah Shade Olowu, Cristian Ramirez Rodriguez, Angelo Thomas Marra, Leon Bernal-Mizrachi

Blood (2024) 144 (Supplement 1): 3748.

https://doi.org/10.1182/blood-2024-208901

Published: 2024

Journal Articles

HCT-Adapted ELN 2022 Risk Classification: Validation of a Very Poor Risk Group (Adverse-Plus) in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Study on Behalf of the Grupo Español De Trasplante y Terapia Celular (GETH-TC)

Blood (2024) 144 (Supplement 1): 598.

https://doi.org/10.1182/blood-2024-205686

Published: 2024

Journal Articles

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Blood (2024) 144 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2024-205181

Published: 2024

Journal Articles

Immunotherapy May be Preferable to Chemotherapy As Second-Line Treatment for POD24 Follicular Lymphoma (FL) Patients

Blood (2024) 144 (Supplement 1): 1658.

https://doi.org/10.1182/blood-2024-207871

Published: 2024

Journal Articles

Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Blood (2024) 144 (Supplement 1): 1715.

https://doi.org/10.1182/blood-2024-199742

Published: 2024

Journal Articles

Primary Mediastinal B Cell Lymphoma (PMBCL): A Multicentric Observational Study of Spanish Lymphoma Group Geltamo

Almudena Cabero Martínez, Ana García Bacelar, Begoña Mendibil Esquisabel, Javier Nuñez Cespedes, Ana Jiménez Ubieto, Eukene Gainza Gonzalez, Elena Perez Ceballos, Beatriz De La Cruz, Ana Garcia Noblejas, Paula Fernández-Caldas, Norma C. Gutierrez, Blanca Sánchez-González, Rocío Figueroa Mora, Alberto Lopez Garcia, Daniel García Belmonte, Maria Sanchez de Castro, Estefania Cerezo Velasco, Xabier Martin Martitegui, Hugo Daniel Luzardo Henríquez, Jordina Rovira, Luis Antonio Lopez Gomez, Jackeline Solano, Ana Torres Tienza, Maria Stefania Infante, Raquel Santiago Alonso, Raquel Del Campo, Dunia De Miguel Llorente, Alicia Roldán-Pérez, Emilia Pardal, Beatriz Gonzalez Mena, Miguel Ángel Rodríguez Gil, Nazaret Domínguez Velasco, Albert Blanco Juan, Maria Alejandra Blum Dominguez, Javier López Marin, María Peñarrubia-Ponce, Mariana Bastos-Oreiro, Alejandro Martín García-Sancho

Blood (2024) 144 (Supplement 1): 1708.

https://doi.org/10.1182/blood-2024-198904

Published: 2024

Journal Articles

A New Prognostic Index Including Baseline Clinico-Biological Variables Predicts Outcome in Plasmablastic Neoplasms

Blood (2024) 144 (Supplement 1): 4478.

https://doi.org/10.1182/blood-2024-212008

Published: 2024

Journal Articles

Real World Epidemiology and Treatment Strategies of Limited Stage Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Leyre Bento, Fernando Martín Moro, Antonio Gutierrez, Ana Jiménez Ubieto, Alberto López, Blanca Sánchez González, Belén Navarro, Alicia Segura, Mireia Franch, Ana García-Noblejas, Eva Donato, Alejandro Martín García-Sancho, Beatriz De La Cruz, Alfonso Ortiz Algarra, Roberto Trelles-Martínez, Javier López, Carlos Grande, Mariana Bastos-Oreiro

Blood (2024) 144 (Supplement 1): 4471.

https://doi.org/10.1182/blood-2024-203615

Published: 2024

Journal Articles

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation in a Spanish Multicenter Cohort on Behalf of Geth

Blood (2024) 144 (Supplement 1): 4884.

https://doi.org/10.1182/blood-2024-204722

Published: 2024

Journal Articles

Safety Profile in Patients with Chronic Lymphocytic Leukemia Undergoing Treatment with 1st and 2nd Generation Bruton Tyrosine Kinase Inhibitors: Multicentric Real-World Experience

Alberto Lopez Garcia, Alfonso Garcia, Ester Macia, Daniel Morillo, Carolina Miranda, Laura Bermejo, Maria Yuste, Maria Pilar Llamas Sillero, Raul Cordoba

Blood (2023) 142 (Supplement 1): 6551.

https://doi.org/10.1182/blood-2023-181722

Published: 2023

Journal Articles

Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes for Patients with B-Cell Lymphoma

Gloria Iacoboni, Angel Serna, Victor Navarro Garces, Ana Jimenez Ubieto, Evelyn Valencia, Alberto Lopez Garcia, Itziar Carro, Sergi Camarillas, Josu Iraola, Lucia Medina, Gala Vega, Maria Pozas, Anna Maria Sureda Balari, Raul Cordoba, Miguel Canales, Francesc Bosch, Pere Barba, Pau Abrisqueta Costa

Blood (2023) 142 (Supplement 1): 310.

https://doi.org/10.1182/blood-2023-184883

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

In multiple myeloma patients, autologous stem cell transplants abrogate the difference of treating them with two or three drug combinations: Real world data from a single institution in a middle-income country.

The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants.

Enumeration of plasma cells in the bone marrow of persons with multiple myeloma: Correlation between conventional panoptical microscopy of the aspirate, flow cytometry and bone marrow biopsy.

Castleman disease as a spectrum: Characterization of novel subtypes using data from the spanish GELTAMO registry

Evaluating a doctor-in-the-loop AI-agent for multiple myeloma chart reviews

The number of CD34 cells employed in autologous hematopoietic stem cell transplantation in persons with multiple sclerosis is unrelated to the neurological outcome of the procedure. experience in 1417 patients.

Patients with multiple sclerosis above age 60 have neurological responses to autologous hematopoietic stem cell transplants similar to younger individuals: A single center experience

Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance ?

Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study

Treatment-Related Neuropathy Following Brentuximab-Vedotin in African Americans Treated for Lymphoma: A Retrospective Chart Review

HCT-Adapted ELN 2022 Risk Classification: Validation of a Very Poor Risk Group (Adverse-Plus) in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Study on Behalf of the Grupo Español De Trasplante y Terapia Celular (GETH-TC)

Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)

Immunotherapy May be Preferable to Chemotherapy As Second-Line Treatment for POD24 Follicular Lymphoma (FL) Patients

Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Primary Mediastinal B Cell Lymphoma (PMBCL): A Multicentric Observational Study of Spanish Lymphoma Group Geltamo

A New Prognostic Index Including Baseline Clinico-Biological Variables Predicts Outcome in Plasmablastic Neoplasms

Real World Epidemiology and Treatment Strategies of Limited Stage Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation in a Spanish Multicenter Cohort on Behalf of Geth

Safety Profile in Patients with Chronic Lymphocytic Leukemia Undergoing Treatment with 1st and 2nd Generation Bruton Tyrosine Kinase Inhibitors: Multicentric Real-World Experience

Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes for Patients with B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only